Tag: CymaBay Therapeutics
November 25, 2019
CymaBay Therapeutics Stops Clinical Development of Seladelpar
The company announced it is terminating a Phase 2b study, a Phase 2 study and putting on hold seladelpar in... November 4, 2019
CymaBay Therapeutics Reaches Target Enrollment in ENHANCE Phase 3 Study
The study is evaluating its seladelpar in patients with primary biliary cholangitis with enrollment to be completed by end of... June 18, 2019